Oncogene - Table of Contents alert Volume 31 Issue 16

TABLE OF CONTENTS Volume 31, Issue 16 (April 2012) In this issue Review Original Articles Short Communication Also new AOP Advertisement tONCO™ has all of the tools you need, including: * Spontaneous tumor models for breast & colon cancer. * Tumor tissues or cohorts of allografted animals. * Patient-derived xenograft models. * Bioluminescent imaging technologies. Learn more. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Genetics and the Wellcome Trust present: The Genomics of Common Diseases 2012 September 19-22, 2012 - Potomac, MD, USA For more information and to register, visit: www.nature.com/natureconferences/gcd2012   Review Top Standard of care therapy for malignant glioma and its effect on tumor and stromal cells T S Jones and E C Holland Oncogene 2012 31: 1995-2006; advance online publication, September 12, 2011; 10.1038/onc.2011.398 Abstract | Full Text Original Articles Top Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma C Lu, X Zhu, M C Willingham and S-Y Cheng Oncogene 2012 31: 2007-2016; advance online publication, September 12, 2011; 10.1038/onc.2011.390 Abstract | Full Text GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells I M Chu, A M Michalowski, M Hoenerhoff, K M Szauter, D Luger, M Sato, K Flanders, A Oshima, K Csiszar and J E Green Oncogene 2012 31: 2017-2027; advance online publication, September 5, 2011; 10.1038/onc.2011.382 Abstract | Full Text Different phenotypic consequences of simultaneous versus stepwise Apc loss J M Fischer, A J Miller, D Shibata and R M Liskay Oncogene 2012 31: 2028-2038; advance online publication, September 5, 2011; 10.1038/onc.2011.385 Abstract | Full Text Identification of microprocessor-dependent cancer cells allows screening for growth-sustaining micro-RNAs D Peric, K Chvalova and G Rousselet Oncogene 2012 31: 2039-2048; advance online publication, September 12, 2011; 10.1038/onc.2011.391 Abstract | Full Text The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells M Durán-Prado, M D Gahete, M Hergueta-Redondo, A J Martínez-Fuentes, J Córdoba-Chacón, J Palacios, F Gracia-Navarro, G Moreno-Bueno, M M Malagón, R M Luque and J P Castaño Oncogene 2012 31: 2049-2061; advance online publication, September 19, 2011; 10.1038/onc.2011.389 Abstract | Full Text Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis V Davalos, C Moutinho, A Villanueva, R Boque, P Silva, F Carneiro and M Esteller Oncogene 2012 31: 2062-2074; advance online publication, August 29, 2011; 10.1038/onc.2011.383 Abstract | Full Text Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models V Härmä, M Knuuttila, J Virtanen, T Mirtti, P Kohonen, P Kovanen, A Happonen, S Kaewphan, I Ahonen, O Kallioniemi, R Grafström, J Lötjönen and M Nees Oncogene 2012 31: 2075-2089; advance online publication, September 26, 2011; 10.1038/onc.2011.396 Abstract | Full Text An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer A Mamo, L Cavallone, S Tuzmen, C Chabot, C Ferrario, S Hassan, H Edgren, O Kallioniemi, O Aleynikova, E Przybytkowski, K Malcolm, S Mousses, P N Tonin and M Basik Oncogene 2012 31: 2090-2100; advance online publication, September 5, 2011; 10.1038/onc.2011.386 Abstract | Full Text Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro E Noetzel, M Rose, J Bornemann, M Gajewski, R Knüchel and E Dahl Oncogene 2012 31: 2101-2114; advance online publication, September 12, 2011; 10.1038/onc.2011.403 Abstract | Full Text Short Communication Top Integrity of mTORC2 is dependent on the rictor Gly-934 site R Aimbetov, C-H Chen, O Bulgakova, D Abetov, A K Bissenbaev, R I Bersimbaev and D D Sarbassov Oncogene 2012 31: 2115-2120; advance online publication, September 12, 2011; 10.1038/onc.2011.404 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.